Senate Republicans block Dem attempt to end AI prior authorization in Medicare

Senate Republicans blocked an attempt by Democrats on Thursday to stop a Trump administration pilot program for Medicare that ...

Kalshi Opens Betting Market For Pharmaceutical Trials And FDA Decisions

Gamblers can now bet on how experimental drugs will perform in clinical trials—and if they’ll get FDA approval.

Dassault Systemes in talks to buy drug trial software firm ArisGlobal, FT reports

French software maker Dassault Systemes is in talks to buy drug-trial ​software maker ArisGlobal from Nordic Capital ‌for ...

One of the world’s most prominent hospitals is testing how AI can revolutionize health care

Mayo Clinic, one of the world’s most well-known hospital systems, is using AI in hopes of improving patient care and, ...
MassDevice

Fractyl says its single single catheter treatment maintained most GLP-1 weight loss

Fractyl reported clinical trial results demonstrating that patients maintained up to 84% of GLP-1-induced weight loss with ...

Viz.ai to Support the MINUTE Trial, a Landmark Multicenter Study Evaluating the SCUBA Technique for the Treatment of Intracerebral Hemorrhage

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced its support for the Minimally Invasive Neurosurgery Trial for Ultra-early Treatment (MINUTE) Trial ...
Healio

Computer prompts can significantly reduce needless broad-spectrum antibiotic use in cancer

Patients with cancer frequently receive broad-spectrum antibiotics, even if they are at low risk for antimicrobial-resistant infections.A computer prompt that notifies clinicians that a patient would ...
Johns Hopkins Medicine

Virtual Tumor Predict Response to Liver Cancer Immunotherapy

Researchers @hopkinskimmel and @HopkinsMed develop methods to predict which #livercancer patients do best with combination ...
The BMJ

Contemporary hormonal contraception and colorectal cancer in premenopausal women: nationwide cohort study

Objective To assess the effect of different types of contemporary hormonal contraceptives on the risk of developing ...
Le Lézard

Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis

Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that patient enrollment was ...
Le Lézard

PureTech Founded Entity Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis ...

PureTech Health plc (LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, is pleased to note ...